Evaluation of the effect of Lactobacillus reuteri V3401 on biomarkers of inflammation, cardiovascular risk and liver steatosis in obese adults with metabolic syndrome: a randomized clinical trial (PROSIR)

Evaluation of the effect of Lactobacillus reuteri V3401 on biomarkers of inflammation, cardiovascular risk and liver steatosis in obese adults with metabolic syndrome: a randomized clinical trial (PROSIR)

Abstract Background Obesity is characterized by increased fat mass and is associated with the development of insulin resistance syndrome (IRS), usually known as metabolic syndrome. The alteration of the intestinal microbiota composition has a role in the development of IRS associated with obesity, a...

Full description

Bibliographic Details
Main Authors: Carmen Tenorio-Jiménez, María José Martínez-Ramírez, Mercedes Tercero-Lozano, Carmen Arraiza-Irigoyen, Isabel Del Castillo-Codes, Josune Olza, Julio Plaza-Díaz, Luis Fontana, Jairo H. Migueles, Mónica Olivares, Ángel Gil, Carolina Gomez-Llorente
Format: Article
Language:English
Published: BMC 2018-11-01
Series:BMC Complementary and Alternative Medicine
Subjects:
Human adults
Insulin resistance syndrome
Lactobacillus reuteri V3401
Non-alcoholic fatty liver disease
Obesity
Probiotics
Online Access:http://link.springer.com/article/10.1186/s12906-018-2371-x

Internet

http://link.springer.com/article/10.1186/s12906-018-2371-x

Similar Items